Skip to content

10x Genomics

US · TXG #1311 by market cap Listed 2019
51.80 -5.58 -9.72%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Quant vs Street three independent views, side by side

StockVane factor grade
C
Momentum strategy signal
Hold
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

✦ Quant Analyst Revision Trend how this is computed

Mixed
1 1
■ Upgrades■ Downgrades
  • 1 upgrade vs 1 downgrade among tracked analyst rating changes.
  • Most recent: William Blair moved from Hold to Buy on 2026-04-20.

Analyst consensus 13 analysts

Buy
Avg price target 76.27 +47.2%
Price target rangecurrent 51.80
Low60.00
Avg76.27
High110.00
Buy 38% Hold 62% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-11 Stephens -- Hold 65.00
2026-11-09 UBS -- Hold 61.00
2026-11-09 Barclays -- Buy 70.00
2026-11-09 J.P. Morgan -- Hold 65.00
2026-11-06 CCORF -- Buy 100.00
2026-11-06 UBS -- Hold 61.00
2026-11-06 Piper Sandler -- Hold 80.00
2026-11-06 BofA Securities -- Hold --
2026-11-06 Stifel -- Buy 68.00
2026-11-06 Citi -- Hold 60.00
2026-11-06 Barclays -- Buy 70.00
2026-11-05 RBC Capital -- Hold 70.00
2026-10-12 CCORF -- Buy 100.00
2026-10-09 BofA Securities -- Hold 80.00
2026-10-07 Barclays -- Buy 110.00
2026-09-29 William Blair -- Buy --
2026-09-29 Leerink Partners -- Hold 90.00
2026-09-25 Argus Research -- Buy 110.00
2026-09-01 RBC Capital -- Hold 70.00
2026-08-10 CCORF -- Buy 60.00
2026-08-07 William Blair -- Buy --
2026-08-07 BofA Securities -- Hold --
2026-08-07 Jefferies -- Buy 53.00
2026-08-07 Stifel -- Buy 50.00
2026-08-07 Citi -- Hold 50.00

Price target trend monthly average, last 3 years

Recent rating changes

DateFirmChangeTarget
2026-04-20 William Blair Hold → Buy --
2025-12-11 Citi Buy → Hold 18.00

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-11-05 After close ±18.56% +2.10% (in line)
2026/Q2 2026-08-06 After close ±13.67% +14.10% (beat)
2026/Q1 2026-05-07 After close ±13.21% -3.66% (in line)
2025/Q4 2026-02-12 After close ±16.03% +3.48% (in line)
2025/Q3 2025-11-06 After close ±21.63% +17.31% (in line)
2025/Q2 2025-08-07 After close ±20.99% -3.98% (in line)
2025/Q1 2025-05-08 After close ±30.30% +1.62% (in line)
2024/Q4 2025-02-12 After close ±18.78% -0.50% (in line)
2024/Q3 2024-10-29 After close ±20.34% +4.43% (in line)
2024/Q2 2024-08-08 After close ±15.88% +4.50% (in line)
2024/Q1 2024-04-30 After close ±17.27% -8.06% (in line)
2023/Q4 2024-02-15 After close ±17.07% +0.79% (in line)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 20:02:38 · For reference only, not investment advice and not tailored to your situation.

10x Genomics discussion 0 comments

Add a comment